Quarterly report · Q3
2370.TEDINET S100P0C7
Period2021-10-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥470m | 2021-10-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥683m | 2020-10-01 → 2021-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥512m | 2020-10-01 → 2021-06-30 | Standalone | Net sales |
| Operating income | −¥988m | 2021-10-01 → 2022-06-30 | Standalone | Operating income |
| Operating income | −¥792m | 2020-10-01 → 2021-06-30 | Standalone | Operating income |
| Ordinary income | −¥984m | 2021-10-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥871m | 2020-10-01 → 2021-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥577m | 2020-10-01 → 2021-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥985m | 2021-10-01 → 2022-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥545m | 2020-10-01 → 2021-06-30 | Standalone | Income before income taxes |
| Net income | −¥989m | 2021-10-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | −¥843m | 2020-10-01 → 2021-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥549m | 2020-10-01 → 2021-06-30 | Standalone | Profit loss |
| Total assets | ¥6.3bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥5.4bn | at 2021-09-30 | Standalone | Assets |
| Total assets | ¥5.7bn | at 2021-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥539m | at 2022-06-30 | Standalone | Liabilities |
| Total liabilities | ¥475m | at 2021-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.7bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.9bn | at 2021-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.2bn | at 2021-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.8bn | at 2022-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.1bn | at 2021-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥-5.11 | 2021-10-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.5 | 2022-04-01 → 2022-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.88 | 2020-10-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.21 | 2020-10-01 → 2021-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.22 | 2021-04-01 → 2021-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.4% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.8% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.2% | at 2021-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 211,730,423 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 178,750,423 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 177,730,423 | at 2021-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-06-30 | −¥386m |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥194,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥194,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2021-10-01 → 2022-06-30 | −¥425m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥470m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥470m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2021-10-01 → 2022-06-30 | −¥178m |
| —segment total | revenue | 2021-10-01 → 2022-06-30 | ¥470m |
| —segment total | revenue external | 2021-10-01 → 2022-06-30 | ¥470m |
| —segment total | segment profit | 2021-10-01 → 2022-06-30 | −¥603m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-06-30 | −¥385m |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥143,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥143,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2020-10-01 → 2021-06-30 | −¥319m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥512m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥512m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2020-10-01 → 2021-06-30 | −¥88m |
| —segment total | revenue | 2020-10-01 → 2021-06-30 | ¥512m |
| —segment total | revenue external | 2020-10-01 → 2021-06-30 | ¥512m |
| —segment total | segment profit | 2020-10-01 → 2021-06-30 | −¥407m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 318
| Item | Context | Value | Unit |
|---|---|---|---|
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Note on change of independent auditors financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Original text (Japanese)当社は子会社がありませんので、四半期連結財務諸表を作成しておりません。 | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes revenue recognition quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |